Italia markets closed

Johnson & Johnson (JNJ)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
149,91+0,06 (+0,04%)
Alla chiusura: 04:00PM EDT
149,99 +0,08 (+0,05%)
Dopo ore: 07:31PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente149,85
Aperto150,00
Denaro149,99 x 900
Lettera150,00 x 800
Min-Max giorno149,19 - 150,09
Intervallo di 52 settimane143,13 - 175,97
Volume5.536.153
Media Volume7.594.779
Capitalizzazione360,785B
Beta (5 anni mensile)0,55
Rapporto PE (ttm)22,27
EPS (ttm)6,73
Prossima data utili17 lug 2024
Rendimento e dividendo (futuro)4,96 (3,31%)
Data ex dividendo20 mag 2024
Stima target 1A172,72
  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA